Results 21 to 30 of about 2,406 (151)
Introduction: Accurately identifying patients with pneumocystis pneumonia (PCP) presents considerable challenges, primarily relying on clinical suspicion.
Sonu Kumari Agarwal +2 more
doaj +2 more sources
Co‐trimoxazole prophylaxis for children who are HIV‐exposed and uninfected: a systematic review
Abstract Introduction Co‐trimoxazole prophylaxis is recommended for children born to women with HIV to protect those who acquire HIV from opportunistic infections, severe bacterial infections and malaria. With scale‐up of maternal antiretroviral therapy, most children remain HIV‐exposed uninfected (HEU) and the benefits of universal co‐trimoxazole are ...
Catherine J. Wedderburn +6 more
wiley +1 more source
CONVENTIONAL METHODS FOR THE DIAGNOSIS OF PNEUMOCYSTIS JIROVECII IN IMMUNOCOMPROMISED IRAQI PATIENTS
Background: Pneumocystis jirovecii is the causative agent of pneumocystis pneumonia, one of the most frequent and severe opportunistic infections in immunocompromised patients.
Isa S. Touhali +2 more
doaj +6 more sources
Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitor. Abstract Immune checkpoint inhibitors (ICIs) have successfully treated a number of different types of cancer, which is of great significance for cancer treatment.
Wenxian Wang +79 more
wiley +1 more source
It is still PCP that can stand for Pneumocystis pneumonia: Appeal for generalized use of only one acronym [PDF]
Twenty-years ago, considering the host specificity of Pneumocystis species, the human-derived Pneumocystis, Pneumocystis carinii formae specialis hominis, was renamed Pneumocystis jirovecii.
Calderón Sandubete, Enrique José +14 more
core +1 more source
Bendamustine and pneumocystis pneumonia: A systematic review
Abstract Background Bendamustine, a bifunctional mechlorethamine alkylating agent, is used in the treatment of patients with hematologic malignancies. Myelosuppression and cytotoxic effect arises quite often after bendamustine treatment. To date, there have been no recommendations for routine chemoprophylaxis for Pneumocystis carinii pneumonia (PCP) in
Atousa Hakamifard +3 more
wiley +1 more source
Comorbidities in women living with HIV: A systematic review
Abstract Objectives Effective antiretroviral therapy (ART) has improved the life expectancy of women living with HIV (WLWH). This population is now experiencing age‐related comorbidities. This systematic review presents the current understanding of the prevalence and impact of comorbidities in WLWH in the modern ART era. Methods MEDLINE and Embase were
Sonia Raffe +4 more
wiley +1 more source
pneumonia in pediatric patients: an analysis of 15 confirmed consecutive cases during 14 years [PDF]
PurposePneumocystis jirovecii pneumonia occurs in various immunocompromised patients. Despite the prophylaxis strategies in clinical practice, certain patients develop P. jirovecii pneumonia. This study was performed to investigate pediatric cases with P.
Kyung-Ran Kim +3 more
doaj +1 more source
The origin and emergence of resistance to antifungal compounds are evaluated and potential “hot spots” identified for major life‐theatening fungal human pathogens in medical and environmental settings. Abstract Fungal propagules existing in the natural environment can easily be transmitted to the human body, mostly by inhalation of contaminated air or ...
Ulrich Gisi
wiley +1 more source
In the context of deciphering the metabolic strategies of the obligate pathogenic fungi in the genus Pneumocystis, the genomes of three species (P. carinii, P. murina, and P.
Aleksey Porollo +4 more
doaj +1 more source

